Graefen M - Search Results

1

Conditional survival of stage III non-seminoma testis cancer patients.

Incesu RB, Barletta F, Tappero S, Morra S, Garcia CC, Scheipner L, Piccinelli ML, Tian Z, Saad F, Shariat SF, de Cobelli O, Ahyai S, Chun FKH, Longo N, Terrone C, Briganti A, Tilki D, Graefen M, Karakiewicz PI. Incesu RB, et al. Among authors: graefen m. Urol Oncol. 2023 Oct;41(10):435.e11-435.e18. doi: 10.1016/j.urolonc.2023.06.005. Epub 2023 Aug 7. Urol Oncol. 2023. PMID: 37558516

2

Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Huland E, Scardino PT, Kattan MW, Huland H. Graefen M, et al. J Urol. 2002 Mar;167(3):1306-9. J Urol. 2002. PMID: 11832719

3

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.

Graefen M, Karakiewicz PI, Cagiannos I, Klein E, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, Scardino PT, Kattan MW. Graefen M, et al. J Clin Oncol. 2002 Feb 15;20(4):951-6. doi: 10.1200/JCO.2002.20.4.951. J Clin Oncol. 2002. PMID: 11844816

4

Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?

Cagiannos I, Graefen M, Karakiewicz PI, Ohori M, Eastham JA, Rabbani F, Fair W, Wheeler TM, Hammerer PG, Haese A, Erbersdobler A, Huland H, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: graefen m. J Clin Oncol. 2002 Apr 15;20(8):2025-30. doi: 10.1200/JCO.2002.08.123. J Clin Oncol. 2002. PMID: 11956261

5

Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

Palisaar RJ, Graefen M, Karakiewicz PI, Hammerer PG, Huland E, Haese A, Fernandez S, Erbersdobler A, Henke RP, Huland H. Palisaar RJ, et al. Among authors: graefen m. Eur Urol. 2002 Feb;41(2):155-61. doi: 10.1016/s0302-2838(01)00025-2. Eur Urol. 2002. PMID: 12074402

6

International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein E, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A, Erbersdobler A, Eastham JA, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, van der Kwast TH, Scardino PT, Kattan MW. Graefen M, et al. J Clin Oncol. 2002 Aug 1;20(15):3206-12. doi: 10.1200/JCO.2002.12.019. J Clin Oncol. 2002. PMID: 12149292

7

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Fernandez S, Noldus J, Erbersdobler A, Huland H, Scardino PT, Kattan MW. Graefen M, et al. Urol Oncol. 2002 Jul-Aug;7(4):141-6. doi: 10.1016/s1078-1439(02)00177-1. Urol Oncol. 2002. PMID: 12474529

8

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, Blonski J, Fernandez S, Erbersdobler A, Huland H. Graefen M, et al. Eur Urol. 2003 Jan;43(1):6-10; discussion 11. doi: 10.1016/s0302-2838(02)00497-9. Eur Urol. 2003. PMID: 12507538

9

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: graefen m. J Urol. 2003 Nov;170(5):1798-803. doi: 10.1097/01.ju.0000091805.98960.13. J Urol. 2003. PMID: 14532779

10

Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.

Augustin H, Eggert T, Wenske S, Karakiewicz PI, Palisaar J, Daghofer F, Huland H, Graefen M. Augustin H, et al. Among authors: graefen m. J Urol. 2004 Jan;171(1):177-81. doi: 10.1097/01.ju.0000099827.77355.a7. J Urol. 2004. PMID: 14665871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

960 results

Search Page

Filters